Vitexin attenuates epithelial ovarian cancer cell viability and motility in vitro and carcinogenesis in vivo via p38 and ERK1/2 pathways related VEGFA
- DOI
- 10.21037/atm-20-5586
- Published
- 2020-09
- Container
- Annals of Translational Medicine
- Publisher
- AME Publishing Company
- Open access
- unknown
Credibility signals
serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.21037/atm-20-5586,
title = {Vitexin attenuates epithelial ovarian cancer cell viability and motility in vitro and carcinogenesis in vivo via p38 and ERK1/2 pathways related VEGFA},
author = {Shuzhen Zhao and Xinlei Guan and Ruijie Hou and Xueying Zhang and Fang Guo and Zhifang Zhang and Caihong Hua},
year = {2020},
journal = {Annals of Translational Medicine},
doi = {10.21037/atm-20-5586},
url = {https://doi.org/10.21037/atm-20-5586}
}RIS
TY - JOUR TI - Vitexin attenuates epithelial ovarian cancer cell viability and motility in vitro and carcinogenesis in vivo via p38 and ERK1/2 pathways related VEGFA AU - Shuzhen Zhao AU - Xinlei Guan AU - Ruijie Hou AU - Xueying Zhang AU - Fang Guo AU - Zhifang Zhang AU - Caihong Hua PY - 2020 JO - Annals of Translational Medicine DO - 10.21037/atm-20-5586 UR - https://doi.org/10.21037/atm-20-5586 ER -
APA
Zhao, S., Guan, X., Hou, R., Zhang, X., Guo, F., Zhang, Z., & Hua, C. (2020). Vitexin attenuates epithelial ovarian cancer cell viability and motility in vitro and carcinogenesis in vivo via p38 and ERK1/2 pathways related VEGFA. Annals of Translational Medicine. https://doi.org/10.21037/atm-20-5586
Source records
- crossref · retrieved 2026-11-04T01:48:24.886Z